P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit From Adjuvant Chemotherapy

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1487
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.16-49 Which Nomogram Is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2n1m0) Non-Small Cell Lung Cancer in Elderly Patients

Annals of Surgical Oncology
OncologySurgery
2014English

Why Do Pathological Stage IA Lung Adenocarcinomas Vary From Prognosis?: A Clinicopathologic Study of 176 Patients With Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

P2.16-34 Visceral Pleural Invasion Is Closely Associated With Nodal Spread in cStage IA Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-63 the Value of Adjuvant Chemotherapy in Patients With Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.09-26 Clinical Significance of Subcellular Localization of Maspin in Patients With Pathological Stage IA Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy